Wed, Jan 28, 2015, 5:51 AM EST - U.S. Markets open in 3 hrs 39 mins


% | $
Quotes you view appear here for quick access.

PDL BioPharma, Inc. Message Board

pharmarobot 2 posts  |  Last Activity: Dec 12, 2014 7:48 AM Member since: Dec 8, 1997
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Executive Compensation

    by pharmarobot Dec 10, 2014 11:31 AM
    pharmarobot pharmarobot Dec 12, 2014 7:48 AM Flag

    2013/2014 2013/2014 LTIP
    LTIP Cash Value of
    Name Title Payment Restricted Stock
    John P. McLaughlin President and Chief$1,407,000 $201,000
    Executive Officer
    Christopher StoneVice President, General Counsel $774,000 $110,600
    and Secretary
    Peter Garcia Vice President and Chief $735,000 $105,000
    Financial Officer
    Danny Hart Vice President, $525,000 $75,000
    Business Development
    David Montez Controller and Chief $211,200 $30,200
    Accounting Officer

  • pharmarobot by pharmarobot Dec 10, 2014 11:31 AM Flag

    Clearly the management team does't have much confidence in the stock price appreciating, since substantially all of the compensation recently published is in cash. This is not surprising, since once the Queen royalties expire in the first quarter of 2016, their cash flow will be cut by more than 80%. The real question is why the stock price hasn't decline more.

7.72+0.09(+1.18%)Jan 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.